Navigation Links
Covance Central Laboratory Services Ranks #1 in Global Investigator Satisfaction Survey
Date:10/31/2011

PRINCETON, N.J., Oct. 31, 2011 /PRNewswire/ -- Covance Inc. (NYSE: CVD) today announced that its central laboratory services ranked first, by a wide margin, in an independent global survey of 550 physician investigators participating in clinical trials. The majority (54 percent) of the study participants named Covance central laboratory services as their "most preferred" central laboratory, with investigators citing Covance three times more often than the nearest competitor.  Investigators also reported having the "best overall relationship" with Covance, rating it 8.4 on a scale of 1 to 10.  

The survey also determined that investigators who participate in a clinical trial with their preferred central laboratory are overwhelmingly satisfied (98 percent). When pharmaceutical sponsors select investigators' least preferred central laboratory, satisfaction drops significantly. Respondents cited central laboratory preference as a key driver of satisfaction with the pharmaceutical sponsor as well, with more than 85 percent of investigators stating that they are more satisfied and willing to work with a sponsor on trials when they have selected their preferred central laboratory.  Ninety-four percent of investigators indicate the central laboratory selected by the sponsor impacts their (and their staffs') success, day-to-day activities, and willingness to work with a particular sponsor on future studies.

Survey results showed that factors that lead to a strong relationship between investigators and a central laboratory include effective communication, the laboratory's reputation for reliability and quality, and easy-to-use collection kits. Respondents ranked Covance first in all of the key performance metrics, from customer service to timely and accurate reporting.

"We make every effort to understand the challenges investigators face and tailor our opera
'/>"/>

SOURCE Covance Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Covance Announces Integrated Radiolabeled Clinical Pharmacology Studies
2. Covance Receives Highest Level of Phase I Accreditation
3. Covance Inc. Invites You to Join the Webcast of Its Fourth Quarter 2009 Financial Results Conference Call
4. Covance to Present at the 28th Annual J.P. Morgan Healthcare Conference
5. Rules-Based Medicine Forms Biomarker Alliance With Covance Inc.
6. Covance Enters Into a Biomarker Alliance With Rules-Based Medicine, Inc.
7. Covance to Present at Piper Jaffray 21st Annual Health Care Conference
8. Covance To Present At The 20th Annual Global Healthcare Services Conference
9. Covance To Present at the Deutsche Bank 35th Annual Health Care Conference
10. Covance to Present at Goldman Sachs 31st Annual Global Healthcare Conference
11. Covance to Present at William Blair & Companys 30th Annual Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... , May 28, 2015   Eli Lilly and Company ... ) will host a webcast on June 11 to discuss ... baricitinib in rheumatoid arthritis. Data from these two trials, RA-BEACON and ... Programme for the EULAR Congress 2015 in Rome, ... from 10:00 to11:00 a.m. Eastern Daylight Time. The live audio ...
(Date:5/28/2015)... 28, 2015  Merck KGaA, Darmstadt, ... and top-quality high-tech products in healthcare, life science ... agreement with the fertility technologies expert Genea Biomedx, ... and helping couples create families. With this partnership, ... a global market leader in drugs for Assisted ...
(Date:5/28/2015)... CHICAGO , May 28, 2015  The ... left health plans and employer groups scrambling to ... by a major managed care plan, retail pharmacy ... United Healthcare,s $13.3 billion purchase of Catamaran, Rite ... recent announcement to purchase Omni-Care for $10 billion ...
Breaking Medicine Technology:Lilly and Incyte Announce Webcast to Discuss Baricitinib Phase III Data 2Lilly and Incyte Announce Webcast to Discuss Baricitinib Phase III Data 3Merck KGaA, Darmstadt, Germany, as Pioneer in Assisted Reproductive Treatments, Takes Leading Role in Fertility Technologies, Announces a Global Collaboration Agreement with Genea Biomedx 2Merck KGaA, Darmstadt, Germany, as Pioneer in Assisted Reproductive Treatments, Takes Leading Role in Fertility Technologies, Announces a Global Collaboration Agreement with Genea Biomedx 3Merck KGaA, Darmstadt, Germany, as Pioneer in Assisted Reproductive Treatments, Takes Leading Role in Fertility Technologies, Announces a Global Collaboration Agreement with Genea Biomedx 4Citizens Rx Addresses Recent PBM Consolidation and Rising Pharmacy Costs 2Citizens Rx Addresses Recent PBM Consolidation and Rising Pharmacy Costs 3
... a global provider of comprehensive sample management solutions ... logistics and virtual sample intelligence, will host its ... May 2012 in Brussels, Belgium from 16:00 – ... Dr. Graham Hughes, Consultant in Pharmaceutical Development and ...
...  NxStage® Medical, Inc. (Nasdaq: NXTM ), ... announced that former NxStage® System One™ patient Nikolas ... following four successful years of more frequent home ... http://photos.prnewswire.com/prnh/20110503/MM94799LOGO ) The freedom ...
Cached Medicine Technology:BioStorage Technologies to Lead Discussion on the Value of a Comprehensive Sample Management Strategy 2Former NxStage Patient Nikolas Gieske Celebrates Kidney Transplant 2Former NxStage Patient Nikolas Gieske Celebrates Kidney Transplant 3
(Date:5/29/2015)... Thursday, May 21st was the inaugural Red Nose Day in ... came together to raise money for kids living in poverty. ... to raising money for children and young people living in ... people at Hands-On Seminars decided to host their own event ... fun and laughter to their visitors, while raising awareness of ...
(Date:5/29/2015)... Belviq for weight loss , also ... medication. In 2012, the FDA approved Belviq specifically ... BMI >30. It is also approved for individuals ... weight-related health condition such as high blood pressure, diabetes, ... for weight loss focuses on the brain’s appetite center. ...
(Date:5/28/2015)... 28, 2015 External Counterpulsation (EECP/ECP) has ... over the United States. There are a growing number ... can experience symptoms of angina and these patients are ... and/or bypass surgery. , “No option” patients are a ... artery disease that is considered unacceptable for heart stent ...
(Date:5/28/2015)... May 28, 2015 AMVETS National Executive ... the Commission on Care established by Congress to examine ... veterans. , Appointed to the commission by Mitch McConnell, ... be one of only 15 voting members on the ... and Accountability Act of 2014. The goal of the ...
(Date:5/28/2015)... Dallas, Texas (PRWEB) May 28, 2015 Park ... 2” Group Dog Training class starting Saturday, June ... in the courtyard of 5831 McCommas Blvd in Dallas, with ... The classes will run for five weeks, with no class ... for the class is $135. , In this Intermediate-to-Advanced level ...
Breaking Medicine News(10 mins):Health News:Groups, such as Hands-On Physical Therapy, Across the Country, Host Their Own Events and Make the Inaugural Red Nose Day a Huge Success 2Health News:Belviq for Weight Loss is Now Available to Qualified Diet Doc Patients Nationwide 2Health News:Belviq for Weight Loss is Now Available to Qualified Diet Doc Patients Nationwide 3Health News:External Counterpulsation (EECP/ECP) a New Heart Disease Therapy Helps People of Calgary with Unstable Angina 2Health News:AMVETS Executive Director Stewart Hickey Appointed to Congressional Commission on Care 2Health News:Dallas-based Park Cities Pet Sitter to Offer “Training and Enrichment 2” Group Dog Training Class Beginning Saturday, June 6th, 2015. 2Health News:Dallas-based Park Cities Pet Sitter to Offer “Training and Enrichment 2” Group Dog Training Class Beginning Saturday, June 6th, 2015. 3
... , TUCSON, Ariz. , ... PRSC ) today announced that Fletcher McCusker , Chairman and ... Company,s operations at the Jefferies 2010 Global Healthcare Services Conference on ... York .   , Providence,s presentation is scheduled for ...
... cheaper and more effective than existing products , WEDNESDAY, ... developed a new formula for a disinfectant that,s effective ... that cause mad cow disease. , The fast-acting disinfectant, ... it could, for instance, be used to rid surgical ...
... N.J. , Jan. 20 Which medical news stories are physicians reading to stay informed about key developments? MedPage ... Every Monday and will be available by visiting MedPageToday.com/Weekly-Top-Ten . , McNeil Expa n ... D r ug R ... z e n in ...
... ... the US marketplace in 2010. , ... Tucson, AZ (PRWEB) January 20, 2010 -- Sunquest, ... business solutions, is introducing its Integrated Clinical Environment™ (Sunquest ICE™) physician portal to ...
... ... solution. State Governments will save billions in medicaid costs, and prevent bankruptcies due to medical ... ... health care reform could bankrupt Medicaid. John Gwynne Prosser II observes California and ...
... Researchers at the University of Minnesota and Minneapolis VA ... brains of those exhibiting post-traumatic stress disorder (PTSD). ... in the study, which for the first time objectively ... magnetic fields in the brain. It,s something conventional brain ...
Cached Medicine News:Health News:Providence Service Corporation to Present at the Jefferies 2010 Global Healthcare Services Conference on Monday, January 25th 2Health News:Providence Service Corporation to Present at the Jefferies 2010 Global Healthcare Services Conference on Monday, January 25th 3Health News:MedPage Today(R) 'What Your Physicians Are Reading' 2Health News:MedPage Today(R) 'What Your Physicians Are Reading' 3Health News:Sunquest Introduces the Integrated Clinical Environment Physician Portal to US Marketplace 2Health News:Author John Gwynne Prosser II Offers "The Solution for Brain Injuries and Bankruptcies" With Free Educational Video Hosted by Google 2Health News:Researchers discover method to objectively identify PTSD 2
This is a 3D transducer for endovaginal imaging in OB/GYN....
Super High Density, 120 field of view, angled handle, multi-frequency, convex endovaginal transducer....
Super High Density, 120 degree field of view, straight handle, multi-frequency, convex endovaginal transducer....
Visualize the prostate in both transverse and longitudinal planes....
Medicine Products: